Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). A Multicenter, Prospective, Controlled, Randomized Trial.

NCT02200146 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT02200146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02200146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). A Multicenter, Prospective, Controlled, Randomized Trial.
Lead sponsor
University of Milano Bicocca
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2009
Completion date
September 30, 2013
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary sarcoidosis